{"id":4572,"date":"2023-09-06T11:25:25","date_gmt":"2023-09-06T10:25:25","guid":{"rendered":"http:\/\/allysonpollock.com\/?page_id=4572"},"modified":"2024-03-04T09:47:47","modified_gmt":"2024-03-04T09:47:47","slug":"essential-medicines","status":"publish","type":"page","link":"https:\/\/allysonpollock.com\/?page_id=4572","title":{"rendered":"Essential medicines"},"content":{"rendered":"\n<p class=\"has-text-color has-link-color wp-elements-b3bdd10f08427c19c86f6e2237e11e6b\" style=\"color:#8b6601\"><a href=\"#em-publications\">Publications<\/a><\/p>\n\n\n\n<p class=\"has-text-color has-link-color wp-elements-a3cc0b9c88614c3a1f674e61b8155ddb\" style=\"color:#8b6601\"><a href=\"#misoprostol-deletion-WHO\">Application to WHO for deletion of misoprostol for postpartum haemorrhage, 29 November 2012<\/a><\/p>\n\n\n\n<p class=\"has-text-color has-link-color wp-elements-76b0b1cffc17c434ee52f9e48014d6ba\" id=\"em-publications\" style=\"color:#7e0606\"><strong>Publications<\/strong><\/p>\n\n\n\n<p>Brhlikova P, Persaud N, Osorio-de-Castro CGS, Pollock AM.&nbsp;<a href=\"https:\/\/doi.org\/10.1136\/bmj-2023-076783\" target=\"_blank\" rel=\"noreferrer noopener\">Essential medicines lists are for high income countries too<\/a>.&nbsp;<em>BMJ<\/em>&nbsp;2023;382:e076783.&nbsp;<a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2023\/09\/BMJ_2023_Brhlikova_EMLsHighIncome.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">download<\/a><\/p>\n\n\n\n<p>Brhlikova P, Deivanayagam TA, Babar Z-U-D, Osorio-de-Castro CGS, Caetano R, Pollock AM.&nbsp;<a href=\"https:\/\/doi.org\/10.1186\/s40545-023-00595-4\" target=\"_blank\" rel=\"noreferrer noopener\">Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation<\/a>. Journal of Pharmaceutical Policy and Practice 2023;16:88.&nbsp;<a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2023\/07\/JOPPP_2023_Brhlikova_EssentialMedicinesConcept.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">download<\/a><\/p>\n\n\n\n<p>Green A, Lyus R, Ocan M, Pollock AM<em>.<\/em>&nbsp;<a href=\"https:\/\/doi.org\/10.1177\/01410768231181263\" target=\"_blank\" rel=\"noreferrer noopener\">Registration of essential medicines in Kenya, Tanzania and Uganda: a retrospective analysis<\/a>.&nbsp;<em>J R Soc Med<\/em>&nbsp;2023:01410768231181263.&nbsp;<a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2023\/06\/JRSM_2023_Green_RegistrationOfEssentialMedicines.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">download<\/a><\/p>\n\n\n\n<p>Baldeh A-O, Millard C, Pollock AM, Brhlikova P<em>.<\/em>&nbsp;<a href=\"https:\/\/doi.org\/10.1186\/s40545-022-00497-x\" target=\"_blank\" rel=\"noreferrer noopener\">Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda<\/a>.&nbsp;<em>Journal of Pharmaceutical Policy and Practice<\/em>&nbsp;2023;16:18.&nbsp;<a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2023\/02\/JPPP_2023_Baldeh_BridgingTheGap.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">download<\/a><\/p>\n\n\n\n<p>Sevcikova P, Pollock AM. <a href=\"https:\/\/asiatimes.com\/2022\/11\/india-jeopardizing-pharmacy-of-the-world-status\/\" target=\"_blank\" rel=\"noreferrer noopener\">India jeopardizing \u2018pharmacy of the world\u2019 status.<\/a> Asia Times. 15 November 2022.<\/p>\n\n\n\n<p>Pollock AM, Sevcikova P.&nbsp;<a href=\"http:\/\/theconversation.com\/unregulated-innovation-indias-medicine-problem-193630\" target=\"_blank\" rel=\"noreferrer noopener\">Unregulated \u2018innovation\u2019: India\u2019s medicine problem<\/a>. The Conversation. 14 November 2022.<\/p>\n\n\n\n<p>Mehta A, Brhlikova P, McGettigan P, Pollock AM, Roderick P, Farooqui, HH.&nbsp;<a href=\"https:\/\/cdn.who.int\/media\/docs\/default-source\/bulletin\/online-first\/blt.22.287908.pdf?sfvrsn=d89d46fb_1\" target=\"_blank\" rel=\"noreferrer noopener\">Systemic antibiotic sales and WHO recommendations, India<\/a>. Bulletin of the World Health Organization Online First: 22 August 2022.&nbsp;<a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2022\/08\/BWHO_2022_Mehta_AntimicrobialsIndia.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">download<\/a><\/p>\n\n\n\n<p>Pollock AM, Ocan M, Sevcikova P.&nbsp;<a href=\"https:\/\/theconversation.com\/east-african-countries-should-prioritise-their-essential-medicines-for-drug-registration-149638\" target=\"_blank\" rel=\"noreferrer noopener\">East African countries should prioritise their essential medicines for drug registration<\/a>. The Conversation 18 Nov 2020.<\/p>\n\n\n\n<p>Lyus R, Pollock AM, Ocan M, Brhlikova P.&nbsp;<a href=\"https:\/\/www.who.int\/bulletin\/volumes\/98\/8\/19-249433\/en\/\" target=\"_blank\" rel=\"noreferrer noopener\">Registration of antimicrobials, Kenya, Uganda and United Republic of Tanzania, 2018<\/a>. Bulletin of the WHO 2020;98(8):530\u2013538.&nbsp;<a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2020\/09\/BWHO_2020_Lyus_RegistrationAntimicrobialsKenyaUgandaAfrica.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">download<\/a><\/p>\n\n\n\n<p>Brhlikova P, Maigetter K, Murison J, Agaba AG, Tusiimire J, Pollock AM.&nbsp;<a href=\"https:\/\/joppp.biomedcentral.com\/articles\/10.1186\/s40545-020-00234-2\" target=\"_blank\" rel=\"noreferrer noopener\">Registration and local production of essential medicines in Uganda<\/a>. Journal of Pharmaceutical Policy and Practice 2020;13(1):31.&nbsp;<a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2020\/09\/JOPPP_2020_Brhlikova_RegistrationLocalProductionEssentialMedicinesUganda.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">download<\/a><\/p>\n\n\n\n<p>McGettigan P, Roderick P, Kadam A, Pollock AM.&nbsp;<a href=\"http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bcp.13503\/full\" target=\"_blank\" rel=\"noreferrer noopener\">Threats to global antimicrobial resistance control; centrally approved and unapproved antibiotic formulations sold in India<\/a>. British Journal of Clinical Pharmacology. 2018.&nbsp;<a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2018\/03\/BJClinPharmacol_2018McGettigan_ThreatsGlobalAMRIndia.pdf\">download<\/a><\/p>\n\n\n\n<p>Millard C, Kadam A, Mahajan R, Pollock AM, Brhlikova P.&nbsp;<a href=\"http:\/\/www.jogh.org\/documents\/issue201801\/jogh-08-010402.htm\" target=\"_blank\" rel=\"noreferrer noopener\">Availability of brands of six essential medicines in 124 pharmacies in Maharashtra<\/a>. Journal of Global Health. 2018;8(1).&nbsp;<a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2018\/01\/JOGH_2018_Millard_AvailabilityEssentialMedicinesMaharashtra.pdf\">download<\/a><\/p>\n\n\n\n<p>McGettigan P, Pollock AM.&nbsp;<a href=\"https:\/\/asiatimes.com\/2017\/10\/india-not-enough-stop-sale-unapproved-antibiotics\/\" target=\"_blank\" rel=\"noreferrer noopener\">India not doing enough to stop sale of unapproved antibiotics<\/a>. Asia Times. 14 October 2017.<\/p>\n\n\n\n<p>Pollock AM, McGettigan P.&nbsp;<a href=\"http:\/\/theconversation.com\/indian-government-not-doing-enough-to-tackle-sale-of-unapproved-antibiotics-85432\" target=\"_blank\" rel=\"noreferrer noopener\">Indian government not doing enough to tackle sale of unapproved antibiotics<\/a>. The Conversation. 11 Oct 2017.<\/p>\n\n\n\n<p>McGettigan P, Roderick P, Kadam A, Pollock AM.&nbsp;<a href=\"http:\/\/www.thelancet.com\/journals\/langlo\/article\/PIIS2214-109X(17)30365-0\/fulltext\" target=\"_blank\" rel=\"noreferrer noopener\">Access, Watch, and Reserve antibiotics in India: challenges for WHO stewardship<\/a>. The Lancet Global Health. 2017;5(11):e1075\u20136.&nbsp;<a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2017\/10\/LancetGH_2017_McGettigan_AntibioticsIndia.pdf\">download<\/a><\/p>\n\n\n\n<p>Ofori-Asenso R, Pollock AM, Brhlikova P.&nbsp;<a href=\"http:\/\/theconversation.com\/poor-prescription-practices-across-africa-are-putting-patients-at-risk-64250\" target=\"_blank\" rel=\"noreferrer noopener\">Poor prescription practices across Africa are putting patients at risk<\/a>. The Conversation. 29 Aug 2016.<\/p>\n\n\n\n<p>Ofori-Asenso R, Brhlikova P, Pollock AM.&nbsp;<a href=\"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-016-3428-8\" target=\"_blank\" rel=\"noreferrer noopener\">Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995\u20132015)<\/a>. BMC Public Health. 2016;16:724.&nbsp;<a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2016\/08\/BMCPublicHealth_2016_OforiAsenso_PrescribingIndicatorsAfrica.pdf\">download<\/a><\/p>\n\n\n\n<p>Leng H, Pollock AM, Sanders D.&nbsp;<a href=\"http:\/\/www.samj.org.za\/index.php\/samj\/article\/view\/10237\" target=\"_blank\" rel=\"noreferrer noopener\">The impact of the Medicines Control Council backlog and fast-track review system on access to innovative and new generic and biosimilar medicines of public health importance in South Africa<\/a>. South African Medical Journal. 2016 Mar 17;106(4):350.&nbsp;<a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2016\/04\/SAMJ_2015_Leng_MCCBacklog.pdf\">download<\/a><\/p>\n\n\n\n<p>Brhlikova P, Harper I, Subedi M, Bhattarai S, Rawal N, Pollock AM.&nbsp;<a href=\"http:\/\/www.globalizationandhealth.com\/content\/11\/1\/25\" target=\"_blank\" rel=\"noreferrer noopener\">Aid conditionalities, international Good Manufacturing Practice standards and local production rights: a case study of local production in Nepal<\/a>. Globalization and Health. 11(25).&nbsp;<a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2015\/06\/GlobalizationHealth_2015_Brhlikova_AidConditionalitiesNepal.pdf\">download<\/a><\/p>\n\n\n\n<p>Millard C, Brhlikova P, Pollock AM.&nbsp;<a href=\"http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0277953615001471\" target=\"_blank\" rel=\"noreferrer noopener\">Social networks and health policy: the case of misoprostol and the WHO model essential medicine list<\/a>. Social Science &amp; Medicine. 2015;132:190\u20136.&nbsp;<a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2015\/05\/SocSciMed_2015_Millard_SocialNetworksMisoprostol.pdf\">download<\/a><\/p>\n\n\n\n<p>McGettigan P, Roderick P, Mahajan R, Kadam A, Pollock, AM.&nbsp;<a href=\"http:\/\/journals.plos.org\/plosmedicine\/article?id=10.1371\/journal.pmed.1001826\" target=\"_blank\" rel=\"noreferrer noopener\">Use of fixed dose combination (FDC) drugs in India: central regulatory approval and sales of FDCs containing non-steroidal anti-inflammatory drugs (NSAIDs), metformin, or psychotropic drugs<\/a>. PLoS Med. 2015;12(5):e1001826.&nbsp;<a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2015\/05\/PLoSMed_2015_McGettigan_FDCRegulationIndia.pdf\">download<\/a><\/p>\n\n\n\n<p>Millard C, Brhlikova P, Pollock AM.&nbsp;<a href=\"http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0277953615001471\">Social networks and health policy: the case of misoprostol and the WHO model essential medicine list<\/a>. Social Science &amp; Medicine. 2015;132:190\u20136.&nbsp;<a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2015\/05\/SocSciMed_2015_Millard_SocialNetworksMisoprostol.pdf\">download<\/a><\/p>\n\n\n\n<p>Leng H, Sanders D, Pollock AM.&nbsp;<a href=\"http:\/\/gabi-journal.net\/pro-generics-policies-and-the-backlog-in-medicines-registration-in-south-africa-implications-for-access-to-essential-and-affordable-medicines.html\">Pro-generics policies and the backlog in medicines registration in South Africa: implications for access to essential and affordable medicines<\/a>. GaBi Journal. 2015;4(2).<\/p>\n\n\n\n<p>Atukunda, EC, Brhlikova P, Agaba AG, Pollock AM.&nbsp;<a href=\"http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0277953615001057\" target=\"_blank\" rel=\"noreferrer noopener\">Civil society organizations and medicines policy change: a case study of registration, procurement, distribution and use of misoprostol in Uganda<\/a>. Social Science &amp; Medicine. 2015;130:242\u20139.&nbsp;<a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2015\/03\/SocSciMed_2015_Atukunda_CSO_Uganda.pdf\">download<\/a><\/p>\n\n\n\n<p>Evans V, Pollock AM.&nbsp;<a href=\"http:\/\/www.thelancet.com\/pdfs\/journals\/landia\/PIIS2213-8587%2814%2970239-6.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">The proliferation of irrational metformin fixed-dose combinations in India<\/a>. The Lancet Diabetes and Endocrinology. 2015;3(2):98\u2013100.&nbsp;<a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2015\/01\/Lancet_2015_Evans_MetforminFDC.pdf\">download<\/a><\/p>\n\n\n\n<p>Birabwa C, Murison J, Evans V, Obua C, Agaba A, Waako P, et al.&nbsp;<a href=\"http:\/\/www.joppp.org\/content\/7\/1\/18\" target=\"_blank\" rel=\"noreferrer noopener\">The availability of six tracer medicines in private medicine outlets in Uganda. Journal of Pharmaceutical Policy and Practice<\/a>. 2014;7(18).&nbsp;<a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2015\/01\/JOPPP_2014_Birabwa_TracerMedicinesUganda.pdf\">download<\/a><\/p>\n\n\n\n<p>Millard C, Pollock AM, Brhlikova P.&nbsp;<a href=\"http:\/\/bmj.com\/cgi\/content\/full\/bmj.g4823?ijkey=zmV3kYnizrZxL5t&amp;keytype=ref\">Evidence versus influence in the WHO procedure for approving essential medicines: misoprostol for maternal health<\/a>. BMJ. 2014;349:g4823.&nbsp;<a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2014\/08\/BMJ_2014_Millard_EvidenceWHOmisoprostol.pdf\">download<\/a><\/p>\n\n\n\n<p>Atukunda EC, Brhlikova P, Agaba AG, Pollock AM.&nbsp;<a href=\"http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0140673613621716\">Registration, procurement, distribution, and use of misoprostol in Uganda: an interview-based observational study<\/a>. The Lancet. 2013;382(Supplement 1):10.&nbsp;<a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2014\/11\/Lancet_2013_Atukunda_MisoprostolUganda.pdf\">download<\/a><\/p>\n\n\n\n<p>Chu CS, Brhlikova P, Pollock AM.&nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/journals.sagepub.com\/doi\/full\/10.1258\/jrsm.2012.120044\" target=\"_blank\">Rethinking WHO guidance: review of evidence for misoprostol use in the prevention of postpartum haemorrhage<\/a>. JRSM. 2012;105:336\u201347. <a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2023\/09\/JRSM_2012_Chu_MisoprostolPostpartum.pdf\" data-type=\"link\" data-id=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2023\/09\/JRSM_2012_Chu_MisoprostolPostpartum.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">download<\/a><\/p>\n\n\n\n<p class=\"has-text-color has-link-color wp-elements-e3a9f82552c8846d2ea6c0133a1e1e2b\" id=\"misoprostol-deletion-WHO\" style=\"color:#7e0606\"><strong>Application to WHO for deletion of misoprostol for postpartum haemorrhage, 29 November 2012<\/strong><\/p>\n\n\n\n<p><a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2024\/03\/WHO_MAR_Pollock-Brhlikova_Misoprostol-PPH-deletion_20121129.pdf\">Letter to WHO Expert Committee on the Selection and Use of Essential Medicines: Medicine Access and Rational Use<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/allysonpollock.com\/wp-content\/uploads\/2024\/03\/WHO_MAR_Misoprostol-PPH-deletion_20130113.pdf\">Application for deletion of misoprostol for PPH prevention<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Publications Application to WHO for deletion of misoprostol for postpartum haemorrhage, 29 November 2012 Publications Brhlikova P, Persaud N, Osorio-de-Castro CGS, Pollock AM.&nbsp;Essential medicines lists are for high income countries too.&nbsp;BMJ&nbsp;2023;382:e076783.&nbsp;download Brhlikova P, Deivanayagam TA, Babar Z-U-D, Osorio-de-Castro CGS, Caetano R, Pollock AM.&nbsp;Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"tags":[],"class_list":["post-4572","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/allysonpollock.com\/index.php?rest_route=\/wp\/v2\/pages\/4572","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/allysonpollock.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/allysonpollock.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/allysonpollock.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/allysonpollock.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4572"}],"version-history":[{"count":0,"href":"https:\/\/allysonpollock.com\/index.php?rest_route=\/wp\/v2\/pages\/4572\/revisions"}],"wp:attachment":[{"href":"https:\/\/allysonpollock.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4572"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/allysonpollock.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4572"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}